Click for best price
CAR TCellBased Drug Market Size, Share 2024
The global CAR T-Cell-Based Drug market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
CD19-targeted Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of CAR T-Cell-Based Drug include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics, Autolus Therapeutics and Sorrento Therapeutics, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
This report aims to provide a comprehensive presentation of the global market for CAR T-Cell-Based Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR T-Cell-Based Drug. This report contains market size and forecasts of CAR T-Cell-Based Drug in global, including the following market information:
Global CAR T-Cell-Based Drug Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the CAR T-Cell-Based Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CAR T-Cell-Based Drug Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global CAR T-Cell-Based Drug Market Segment Percentages, by Type, 2023 (%)
CD19-targeted
BCMA-targeted
Global CAR T-Cell-Based Drug Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global CAR T-Cell-Based Drug Market Segment Percentages, by Application, 2023 (%)
Lymphoma
Multiple Myeloma
Global CAR T-Cell-Based Drug Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global CAR T-Cell-Based Drug Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CAR T-Cell-Based Drug revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies CAR T-Cell-Based Drug revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Outline of Major Chapters:
Chapter 1: Introduces the definition of CAR T-Cell-Based Drug, market overview.
Chapter 2: Global CAR T-Cell-Based Drug market size in revenue.
Chapter 3: Detailed analysis of CAR T-Cell-Based Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CAR T-Cell-Based Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
CAR T-Cell-Based Drug Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 CAR T-Cell-Based Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CAR T-Cell-Based Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CAR T-Cell-Based Drug Overall Market Size
2.1 Global CAR T-Cell-Based Drug Market Size: 2023 VS 2030
2.2 Global CAR T-Cell-Based Drug Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CAR T-Cell-Based Drug Players in Global Market
3.2 Top Global CAR T-Cell-Based Drug Companies Ranked by Revenue
3.3 Global CAR T-Cell-Based Drug Revenue by Companies
3.4 Top 3 and Top 5 CAR T-Cell-Based Drug Companies in Global Market, by Revenue in 2023
3.5 Global Companies CAR T-Cell-Based Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 CAR T-Cell-Based Drug Players in Global Market
3.6.1 List of Global Tier 1 CAR T-Cell-Based Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 CAR T-Cell-Based Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global CAR T-Cell-Based Drug Market Size Markets, 2023 & 2030
4.1.2 CD19-targeted
4.1.3 BCMA-targeted
4.2 By Type - Global CAR T-Cell-Based Drug Revenue & Forecasts
4.2.1 By Type - Global CAR T-Cell-Based Drug Revenue, 2019-2024
4.2.2 By Type - Global CAR T-Cell-Based Drug Revenue, 2025-2030
4.2.3 By Type - Global CAR T-Cell-Based Drug Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global CAR T-Cell-Based Drug Market Size, 2023 & 2030
5.1.2 Lymphoma
5.1.3 Multiple Myeloma
5.2 By Application - Global CAR T-Cell-Based Drug Revenue & Forecasts
5.2.1 By Application - Global CAR T-Cell-Based Drug Revenue, 2019-2024
5.2.2 By Application - Global CAR T-Cell-Based Drug Revenue, 2025-2030
5.2.3 By Application - Global CAR T-Cell-Based Drug Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global CAR T-Cell-Based Drug Market Size, 2023 & 2030
6.2 By Region - Global CAR T-Cell-Based Drug Revenue & Forecasts
6.2.1 By Region - Global CAR T-Cell-Based Drug Revenue, 2019-2024
6.2.2 By Region - Global CAR T-Cell-Based Drug Revenue, 2025-2030
6.2.3 By Region - Global CAR T-Cell-Based Drug Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America CAR T-Cell-Based Drug Revenue, 2019-2030
6.3.2 US CAR T-Cell-Based Drug Market Size, 2019-2030
6.3.3 Canada CAR T-Cell-Based Drug Market Size, 2019-2030
6.3.4 Mexico CAR T-Cell-Based Drug Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe CAR T-Cell-Based Drug Revenue, 2019-2030
6.4.2 Germany CAR T-Cell-Based Drug Market Size, 2019-2030
6.4.3 France CAR T-Cell-Based Drug Market Size, 2019-2030
6.4.4 U.K. CAR T-Cell-Based Drug Market Size, 2019-2030
6.4.5 Italy CAR T-Cell-Based Drug Market Size, 2019-2030
6.4.6 Russia CAR T-Cell-Based Drug Market Size, 2019-2030
6.4.7 Nordic Countries CAR T-Cell-Based Drug Market Size, 2019-2030
6.4.8 Benelux CAR T-Cell-Based Drug Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia CAR T-Cell-Based Drug Revenue, 2019-2030
6.5.2 China CAR T-Cell-Based Drug Market Size, 2019-2030
6.5.3 Japan CAR T-Cell-Based Drug Market Size, 2019-2030
6.5.4 South Korea CAR T-Cell-Based Drug Market Size, 2019-2030
6.5.5 Southeast Asia CAR T-Cell-Based Drug Market Size, 2019-2030
6.5.6 India CAR T-Cell-Based Drug Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America CAR T-Cell-Based Drug Revenue, 2019-2030
6.6.2 Brazil CAR T-Cell-Based Drug Market Size, 2019-2030
6.6.3 Argentina CAR T-Cell-Based Drug Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CAR T-Cell-Based Drug Revenue, 2019-2030
6.7.2 Turkey CAR T-Cell-Based Drug Market Size, 2019-2030
6.7.3 Israel CAR T-Cell-Based Drug Market Size, 2019-2030
6.7.4 Saudi Arabia CAR T-Cell-Based Drug Market Size, 2019-2030
6.7.5 UAE CAR T-Cell-Based Drug Market Size, 2019-2030
7 CAR T-Cell-Based Drug Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis CAR T-Cell-Based Drug Major Product Offerings
7.1.4 Novartis CAR T-Cell-Based Drug Revenue in Global Market (2019-2024)
7.1.5 Novartis Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences CAR T-Cell-Based Drug Major Product Offerings
7.2.4 Gilead Sciences CAR T-Cell-Based Drug Revenue in Global Market (2019-2024)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb CAR T-Cell-Based Drug Major Product Offerings
7.3.4 Bristol-Myers Squibb CAR T-Cell-Based Drug Revenue in Global Market (2019-2024)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 J & J
7.4.1 J & J Company Summary
7.4.2 J & J Business Overview
7.4.3 J & J CAR T-Cell-Based Drug Major Product Offerings
7.4.4 J & J CAR T-Cell-Based Drug Revenue in Global Market (2019-2024)
7.4.5 J & J Key News & Latest Developments
7.5 JW Therapeutics
7.5.1 JW Therapeutics Company Summary
7.5.2 JW Therapeutics Business Overview
7.5.3 JW Therapeutics CAR T-Cell-Based Drug Major Product Offerings
7.5.4 JW Therapeutics CAR T-Cell-Based Drug Revenue in Global Market (2019-2024)
7.5.5 JW Therapeutics Key News & Latest Developments
7.6 FOSUNKite
7.6.1 FOSUNKite Company Summary
7.6.2 FOSUNKite Business Overview
7.6.3 FOSUNKite CAR T-Cell-Based Drug Major Product Offerings
7.6.4 FOSUNKite CAR T-Cell-Based Drug Revenue in Global Market (2019-2024)
7.6.5 FOSUNKite Key News & Latest Developments
7.7 CARsgen Therapeutics
7.7.1 CARsgen Therapeutics Company Summary
7.7.2 CARsgen Therapeutics Business Overview
7.7.3 CARsgen Therapeutics CAR T-Cell-Based Drug Major Product Offerings
7.7.4 CARsgen Therapeutics CAR T-Cell-Based Drug Revenue in Global Market (2019-2024)
7.7.5 CARsgen Therapeutics Key News & Latest Developments
7.8 Autolus Therapeutics
7.8.1 Autolus Therapeutics Company Summary
7.8.2 Autolus Therapeutics Business Overview
7.8.3 Autolus Therapeutics CAR T-Cell-Based Drug Major Product Offerings
7.8.4 Autolus Therapeutics CAR T-Cell-Based Drug Revenue in Global Market (2019-2024)
7.8.5 Autolus Therapeutics Key News & Latest Developments
7.9 Sorrento Therapeutics
7.9.1 Sorrento Therapeutics Company Summary
7.9.2 Sorrento Therapeutics Business Overview
7.9.3 Sorrento Therapeutics CAR T-Cell-Based Drug Major Product Offerings
7.9.4 Sorrento Therapeutics CAR T-Cell-Based Drug Revenue in Global Market (2019-2024)
7.9.5 Sorrento Therapeutics Key News & Latest Developments
7.10 Mustang Bio
7.10.1 Mustang Bio Company Summary
7.10.2 Mustang Bio Business Overview
7.10.3 Mustang Bio CAR T-Cell-Based Drug Major Product Offerings
7.10.4 Mustang Bio CAR T-Cell-Based Drug Revenue in Global Market (2019-2024)
7.10.5 Mustang Bio Key News & Latest Developments
7.11 Bluebird Bio
7.11.1 Bluebird Bio Company Summary
7.11.2 Bluebird Bio Business Overview
7.11.3 Bluebird Bio CAR T-Cell-Based Drug Major Product Offerings
7.11.4 Bluebird Bio CAR T-Cell-Based Drug Revenue in Global Market (2019-2024)
7.11.5 Bluebird Bio Key News & Latest Developments
7.12 Cellectis
7.12.1 Cellectis Company Summary
7.12.2 Cellectis Business Overview
7.12.3 Cellectis CAR T-Cell-Based Drug Major Product Offerings
7.12.4 Cellectis CAR T-Cell-Based Drug Revenue in Global Market (2019-2024)
7.12.5 Cellectis Key News & Latest Developments
7.13 Allogene Therapeutics
7.13.1 Allogene Therapeutics Company Summary
7.13.2 Allogene Therapeutics Business Overview
7.13.3 Allogene Therapeutics CAR T-Cell-Based Drug Major Product Offerings
7.13.4 Allogene Therapeutics CAR T-Cell-Based Drug Revenue in Global Market (2019-2024)
7.13.5 Allogene Therapeutics Key News & Latest Developments
7.14 Celyad
7.14.1 Celyad Company Summary
7.14.2 Celyad Business Overview
7.14.3 Celyad CAR T-Cell-Based Drug Major Product Offerings
7.14.4 Celyad CAR T-Cell-Based Drug Revenue in Global Market (2019-2024)
7.14.5 Celyad Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. CAR T-Cell-Based Drug Market Opportunities & Trends in Global Market
Table 2. CAR T-Cell-Based Drug Market Drivers in Global Market
Table 3. CAR T-Cell-Based Drug Market Restraints in Global Market
Table 4. Key Players of CAR T-Cell-Based Drug in Global Market
Table 5. Top CAR T-Cell-Based Drug Players in Global Market, Ranking by Revenue (2023)
Table 6. Global CAR T-Cell-Based Drug Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global CAR T-Cell-Based Drug Revenue Share by Companies, 2019-2024
Table 8. Global Companies CAR T-Cell-Based Drug Product Type
Table 9. List of Global Tier 1 CAR T-Cell-Based Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CAR T-Cell-Based Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global CAR T-Cell-Based Drug Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - CAR T-Cell-Based Drug Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - CAR T-Cell-Based Drug Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global CAR T-Cell-Based Drug Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - CAR T-Cell-Based Drug Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - CAR T-Cell-Based Drug Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global CAR T-Cell-Based Drug Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global CAR T-Cell-Based Drug Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global CAR T-Cell-Based Drug Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America CAR T-Cell-Based Drug Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe CAR T-Cell-Based Drug Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia CAR T-Cell-Based Drug Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America CAR T-Cell-Based Drug Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa CAR T-Cell-Based Drug Revenue, (US$, Mn), 2025-2030
Table 30. Novartis Company Summary
Table 31. Novartis CAR T-Cell-Based Drug Product Offerings
Table 32. Novartis CAR T-Cell-Based Drug Revenue (US$, Mn) & (2019-2024)
Table 33. Novartis Key News & Latest Developments
Table 34. Gilead Sciences Company Summary
Table 35. Gilead Sciences CAR T-Cell-Based Drug Product Offerings
Table 36. Gilead Sciences CAR T-Cell-Based Drug Revenue (US$, Mn) & (2019-2024)
Table 37. Gilead Sciences Key News & Latest Developments
Table 38. Bristol-Myers Squibb Company Summary
Table 39. Bristol-Myers Squibb CAR T-Cell-Based Drug Product Offerings
Table 40. Bristol-Myers Squibb CAR T-Cell-Based Drug Revenue (US$, Mn) & (2019-2024)
Table 41. Bristol-Myers Squibb Key News & Latest Developments
Table 42. J & J Company Summary
Table 43. J & J CAR T-Cell-Based Drug Product Offerings
Table 44. J & J CAR T-Cell-Based Drug Revenue (US$, Mn) & (2019-2024)
Table 45. J & J Key News & Latest Developments
Table 46. JW Therapeutics Company Summary
Table 47. JW Therapeutics CAR T-Cell-Based Drug Product Offerings
Table 48. JW Therapeutics CAR T-Cell-Based Drug Revenue (US$, Mn) & (2019-2024)
Table 49. JW Therapeutics Key News & Latest Developments
Table 50. FOSUNKite Company Summary
Table 51. FOSUNKite CAR T-Cell-Based Drug Product Offerings
Table 52. FOSUNKite CAR T-Cell-Based Drug Revenue (US$, Mn) & (2019-2024)
Table 53. FOSUNKite Key News & Latest Developments
Table 54. CARsgen Therapeutics Company Summary
Table 55. CARsgen Therapeutics CAR T-Cell-Based Drug Product Offerings
Table 56. CARsgen Therapeutics CAR T-Cell-Based Drug Revenue (US$, Mn) & (2019-2024)
Table 57. CARsgen Therapeutics Key News & Latest Developments
Table 58. Autolus Therapeutics Company Summary
Table 59. Autolus Therapeutics CAR T-Cell-Based Drug Product Offerings
Table 60. Autolus Therapeutics CAR T-Cell-Based Drug Revenue (US$, Mn) & (2019-2024)
Table 61. Autolus Therapeutics Key News & Latest Developments
Table 62. Sorrento Therapeutics Company Summary
Table 63. Sorrento Therapeutics CAR T-Cell-Based Drug Product Offerings
Table 64. Sorrento Therapeutics CAR T-Cell-Based Drug Revenue (US$, Mn) & (2019-2024)
Table 65. Sorrento Therapeutics Key News & Latest Developments
Table 66. Mustang Bio Company Summary
Table 67. Mustang Bio CAR T-Cell-Based Drug Product Offerings
Table 68. Mustang Bio CAR T-Cell-Based Drug Revenue (US$, Mn) & (2019-2024)
Table 69. Mustang Bio Key News & Latest Developments
Table 70. Bluebird Bio Company Summary
Table 71. Bluebird Bio CAR T-Cell-Based Drug Product Offerings
Table 72. Bluebird Bio CAR T-Cell-Based Drug Revenue (US$, Mn) & (2019-2024)
Table 73. Bluebird Bio Key News & Latest Developments
Table 74. Cellectis Company Summary
Table 75. Cellectis CAR T-Cell-Based Drug Product Offerings
Table 76. Cellectis CAR T-Cell-Based Drug Revenue (US$, Mn) & (2019-2024)
Table 77. Cellectis Key News & Latest Developments
Table 78. Allogene Therapeutics Company Summary
Table 79. Allogene Therapeutics CAR T-Cell-Based Drug Product Offerings
Table 80. Allogene Therapeutics CAR T-Cell-Based Drug Revenue (US$, Mn) & (2019-2024)
Table 81. Allogene Therapeutics Key News & Latest Developments
Table 82. Celyad Company Summary
Table 83. Celyad CAR T-Cell-Based Drug Product Offerings
Table 84. Celyad CAR T-Cell-Based Drug Revenue (US$, Mn) & (2019-2024)
Table 85. Celyad Key News & Latest Developments
List of Figures
Figure 1. CAR T-Cell-Based Drug Segment by Type in 2023
Figure 2. CAR T-Cell-Based Drug Segment by Application in 2023
Figure 3. Global CAR T-Cell-Based Drug Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global CAR T-Cell-Based Drug Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global CAR T-Cell-Based Drug Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CAR T-Cell-Based Drug Revenue in 2023
Figure 8. By Type - Global CAR T-Cell-Based Drug Revenue Market Share, 2019-2030
Figure 9. By Application - Global CAR T-Cell-Based Drug Revenue Market Share, 2019-2030
Figure 10. By Type - Global CAR T-Cell-Based Drug Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global CAR T-Cell-Based Drug Revenue Market Share, 2019-2030
Figure 12. By Application - Global CAR T-Cell-Based Drug Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global CAR T-Cell-Based Drug Revenue Market Share, 2019-2030
Figure 14. By Region - Global CAR T-Cell-Based Drug Revenue Market Share, 2019-2030
Figure 15. By Country - North America CAR T-Cell-Based Drug Revenue Market Share, 2019-2030
Figure 16. US CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2030
Figure 17. Canada CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe CAR T-Cell-Based Drug Revenue Market Share, 2019-2030
Figure 20. Germany CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2030
Figure 21. France CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2030
Figure 23. Italy CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2030
Figure 24. Russia CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia CAR T-Cell-Based Drug Revenue Market Share, 2019-2030
Figure 28. China CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2030
Figure 29. Japan CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2030
Figure 32. India CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America CAR T-Cell-Based Drug Revenue Market Share, 2019-2030
Figure 34. Brazil CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa CAR T-Cell-Based Drug Revenue Market Share, 2019-2030
Figure 37. Turkey CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2030
Figure 38. Israel CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2030
Figure 40. UAE CAR T-Cell-Based Drug Revenue, (US$, Mn), 2019-2030
Figure 41. Novartis CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Gilead Sciences CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Bristol-Myers Squibb CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. J & J CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. JW Therapeutics CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. FOSUNKite CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. CARsgen Therapeutics CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Autolus Therapeutics CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Sorrento Therapeutics CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Mustang Bio CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Bluebird Bio CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Cellectis CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Allogene Therapeutics CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Celyad CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
